Maryland
Kenneth B. Stoller, M.D. is Professor of Clinical Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. He received his medical degree from Johns Hopkins in 1992, his psychiatric residency at the Johns Hopkins Hospital, and a 2-year postdoctoral fellowship in addiction psychiatry at the Behavioral Pharmacology Research Unit at Johns Hopkins. A board-certified psychiatrist, he joined the faculty group at Addiction Treatment Services at Hopkins Bayview, where he served as Medical Director. As part of the faculty there, he was the recipient of a 5-year NIH-funded K23 grant focusing on cost and adherence in drug abuse treatment.” In 2009, Dr. Stoller assumed Directorship of the Johns Hopkins Hospital Broadway Center for Addiction, where he established the first known buprenorphine hub & spoke model. He also serves as Medical Director, Behavioral Health at Johns Hopkins Health Plans, which is comprised of four health insurance plans.
Dr. Stoller is recognized for his expertise in treatment and clinical research involving substance use problems, and in particular, the use of methadone and buprenorphine in the treatment of opioid dependence. His early work on basic human laboratory studies of buprenorphine was followed by a more applied focus, such as establishment of evidence-based MCO policies on issues related to addiction treatment reimbursement. This body of work has centered on efforts that seek to improve outcome and control payor costs through identifying and treating substance use disorder, and through integrating and coordinating co-occurring somatic, mental health, and addiction disorders. Dr. Stoller’s research interests have centered on cost issues as they relate to drug abuse and treatment, methods of enhancing treatment adherence and retention, managed care organization approaches to members with drug abuse, and co-occurring psychiatric, medical, pain and substance use disorders. Recent interests also involve health care reform and integrative care, such as efforts to decrease treatment “silos” by coordinating medical care and behavioral health care management for individuals with co-occurring chronic somatic health and addiction problems as well as severe and persistent mental illness. He has numerous first- and co-authored manuscripts and book chapters on these topics, including the use of adaptive stepped care, voucher-based incentives, behaviorally contingent medication, and integrated treatment of co-occurring disorders in a single setting.
